08:40 AM EST, 11/10/2025 (MT Newswires) -- Belite Bio ( BLTE ) reported a Q3 net loss Monday of $0.65 per diluted share, widening from a loss of $0.28 a year earlier.
Analysts surveyed by FactSet expected a loss of $0.45.
The company did not report any revenue for the quarter ended Sept. 30, as expected.
As of Sept. 30, the company had $275.6 million in cash, liquidity funds, and US Treasury bills, it said.